| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | bivalirudin (Angiox®) |
| Formulation | 250 mg powder for concentrate for solution for injection/infusion |
| Reference number | 63 |
| Indication | Anticoagulant in patients undergoing percutaneous coronary interventions (PCI) |
| Company | The Medicines Company |
| BNF chapter | Cardiovascular system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 22/03/2005 |